Literature DB >> 16052148

Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis.

Ramesh Murthy1, Santosh G Honavar, Sanghamitra Burman, Geeta K Vemuganti, Milind N Naik, Vijay Anand P Reddy.   

Abstract

A 55-year-old Asian Indian woman who had recurrent sebaceous gland carcinoma of the left lower eyelid with orbital extension and regional lymph node metastasis was treated with neoadjuvant chemotherapy, using a combination of carboplatin and 5-fluorouracil. Eyelid-sparing orbital exenteration was performed after 3 cycles of chemotherapy, followed by radiotherapy to the regional lymph nodes. Subsequently, 3 cycles of adjuvant chemotherapy were administered. Significant eyelid and orbital tumor volume reduction was achieved with neoadjuvant chemotherapy, making eyelid-sparing orbital exenteration possible. Chemotherapy also spared the patient from radical neck dissection. The patient had limited morbidity and was free of local, regional, and systemic disease at 26 months of follow-up.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052148     DOI: 10.1097/01.iop.0000169426.57497.24

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  11 in total

1.  Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvant chemotherapy.

Authors:  Ajay Gogia; Neelam Pushker; Seema Sen; Sameer Bakhshi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-25       Impact factor: 3.117

2.  Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study.

Authors:  Saurav Verma; Nipun Kumar; Rachna Meel; Seema Sen; Seema Kashyap; Sanjay Sharma; Neelam Pushker; Deepam Pushpam; Sameer Bakhshi
Journal:  Ocul Oncol Pathol       Date:  2021-05-05

3.  Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours?

Authors:  V Kumar; Y Xu
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

4.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

5.  Neoadjuvant chemotherapy for invasive squamous cell carcinoma of the conjunctiva: A case report.

Authors:  Akshay Gopinathan Nair; Swathi Kaliki; Dilip Kumar Mishra; Vijay Anand Reddy; Milind N Naik
Journal:  Indian J Ophthalmol       Date:  2015-12       Impact factor: 1.848

6.  Sebaceous gland carcinoma: Can we do better?

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

7.  Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients.

Authors:  Yoshiaki Takagawa; Wakana Tamaki; Shigenobu Suzuki; Koji Inaba; Naoya Murakami; Kana Takahashi; Hiroshi Igaki; Yuko Nakayama; Naoyuki Shigematsu; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

8.  Sebaceous carcinoma and systemic chemotherapy.

Authors:  Poonam Joshi; Amit Joshi; Vanita Norohna; Kumar Prabhash; Subhdha Kane; Anil K D'cruz
Journal:  Indian J Med Paediatr Oncol       Date:  2012-10

9.  Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy.

Authors:  Angela Orcurto; Béatrice E Gay; Wendy Jeanneret Sozzi; Michel Gilliet; Serge Leyvraz
Journal:  Case Rep Dermatol       Date:  2014-03-13

10.  A Case Report of Recurrent Metastatic Sebaceous Carcinoma Which Showed Favorable Response Tt Non-Fluorouracil Based Chemotherapy.

Authors:  Shin Hee Lee; Yun Hwa Jung; Ji Yeon Yoo; Hyo Jin Park
Journal:  Am J Case Rep       Date:  2018-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.